NCT03591068View on ClinicalTrials.gov

Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

February 22, 2019

Study Completion Date

February 22, 2019

Conditions
Nasal Polyposis
Interventions
DRUG

Fluticasone Propionate

OPN-375 186 μg BID, Delivered via exhalation delivery system

Trial Locations (2)

77030

University of Texas Health Science Center at Houston, McGovern Medical School, Dept. of Otolaryngology, Head and Neck Surgery, Houston

80045

University of Colorado SOM, Department of Otolaryngology, Aurora

All Listed Sponsors
lead

Optinose US Inc.

INDUSTRY

NCT03591068 - Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video | Biotech Hunter | Biotech Hunter